Company Overview
Snapshot
Founded in December 2006 by Uri Rosenschein, ProCatid Medical operates with 1–10 employees. The company is known for its WIRION system, a distal embolic protection solution. In August 2019, Cardiovascular Systems Inc acquired certain assets and rights related to the WIRION system.
Business overview
ProCatid Medical develops embolic protection solutions for minimally invasive interventional procedures, primarily focusing on stenting. Its core product, WIRION, is a distal embolic protection system featuring an independent filter unit compatible with various guide wires. The system is designed for use in procedures such as carotid, renal, lower limb, coronary, and SVG angioplasty, serving the healthcare and medical device sectors.
Strategic signal
In August 2019, Cardiovascular Systems Inc acquired assets and rights related to ProCatid Medical's WIRION system for $17 million. This acquisition validates the innovative technology developed by ProCatid Medical and signals a strategic move by Cardiovascular Systems Inc to expand its offerings in the embolic protection market, indicating strong commercial potential for the WIRION system.
Log in to access full profile ›Company Intelligence Q&A
- What is ProCatid Medical's primary product?
- ProCatid Medical's primary product is WIRION, a distal embolic protection system designed for use in minimally invasive interventional procedures, particularly stenting.
- When was ProCatid Medical founded?
- ProCatid Medical was founded in December 2006.
- What was a significant corporate development for ProCatid Medical in 2019?
- In August 2019, Cardiovascular Systems Inc acquired certain assets and rights related to ProCatid Medical's WIRION system for $17 million.
- What was a key partnership for ProCatid Medical in 2018?
- In October 2018, Boston Scientific signed a distribution deal with Allium Medical, a parent company of ProCatid Medical.
- Who is a founder of ProCatid Medical?
- Uri Rosenschein is a founder of ProCatid Medical.